vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and SHENANDOAH TELECOMMUNICATIONS CO (SHEN). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $91.6M, roughly 1.8× SHENANDOAH TELECOMMUNICATIONS CO). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 7.2%). Over the past eight quarters, SHENANDOAH TELECOMMUNICATIONS CO's revenue compounded faster (15.0% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Shenandoah Telecommunications Co is a U.S. regional telecom provider offering broadband internet, wireless voice/data services, digital cable TV, and fiber-optic solutions. It serves residential, small business and enterprise clients across Mid-Atlantic states, focusing on underserved rural and suburban markets in Virginia, West Virginia, Maryland and Pennsylvania.
ESPR vs SHEN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $91.6M |
| Net Profit | — | $-5.4M |
| Gross Margin | — | — |
| Operating Margin | 50.6% | -1.0% |
| Net Margin | — | -5.9% |
| Revenue YoY | 143.7% | 7.2% |
| Net Profit YoY | — | -95.8% |
| EPS (diluted) | $0.32 | $-0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $91.6M | ||
| Q3 25 | $87.3M | $89.8M | ||
| Q2 25 | $82.4M | $88.6M | ||
| Q1 25 | $65.0M | $87.9M | ||
| Q4 24 | $69.1M | $85.4M | ||
| Q3 24 | $51.6M | $87.6M | ||
| Q2 24 | $73.8M | $85.8M | ||
| Q1 24 | $137.7M | $69.2M |
| Q4 25 | — | $-5.4M | ||
| Q3 25 | $-31.3M | $-9.4M | ||
| Q2 25 | $-12.7M | $-9.0M | ||
| Q1 25 | $-40.5M | $-9.1M | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | $-29.5M | $-5.3M | ||
| Q2 24 | $-61.9M | $-12.9M | ||
| Q1 24 | $61.0M | $214.7M |
| Q4 25 | 50.6% | -1.0% | ||
| Q3 25 | -11.4% | -8.0% | ||
| Q2 25 | 8.6% | -10.3% | ||
| Q1 25 | -34.0% | -6.9% | ||
| Q4 24 | -6.4% | -6.7% | ||
| Q3 24 | -31.0% | -4.8% | ||
| Q2 24 | 3.5% | -18.5% | ||
| Q1 24 | 52.5% | -4.0% |
| Q4 25 | — | -5.9% | ||
| Q3 25 | -35.9% | -10.5% | ||
| Q2 25 | -15.4% | -10.2% | ||
| Q1 25 | -62.2% | -10.4% | ||
| Q4 24 | — | -3.2% | ||
| Q3 24 | -57.2% | -6.0% | ||
| Q2 24 | -83.9% | -15.0% | ||
| Q1 24 | 44.3% | 310.0% |
| Q4 25 | $0.32 | $-0.13 | ||
| Q3 25 | $-0.16 | $-0.20 | ||
| Q2 25 | $-0.06 | $-0.19 | ||
| Q1 25 | $-0.21 | $-0.19 | ||
| Q4 24 | $-0.14 | $-0.34 | ||
| Q3 24 | $-0.15 | $-0.13 | ||
| Q2 24 | $-0.33 | $-0.24 | ||
| Q1 24 | $0.34 | $4.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $27.3M |
| Total DebtLower is stronger | — | $642.4M |
| Stockholders' EquityBook value | $-302.0M | $880.8M |
| Total Assets | $465.9M | $1.9B |
| Debt / EquityLower = less leverage | — | 0.73× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $27.3M | ||
| Q3 25 | $92.4M | $22.6M | ||
| Q2 25 | $86.1M | $29.1M | ||
| Q1 25 | $114.6M | $87.5M | ||
| Q4 24 | $144.8M | $46.3M | ||
| Q3 24 | $144.7M | $43.1M | ||
| Q2 24 | $189.3M | $43.8M | ||
| Q1 24 | $226.6M | $389.7M |
| Q4 25 | — | $642.4M | ||
| Q3 25 | — | $535.4M | ||
| Q2 25 | — | $513.1M | ||
| Q1 25 | — | $515.8M | ||
| Q4 24 | — | $418.0M | ||
| Q3 24 | — | $345.2M | ||
| Q2 24 | — | $297.4M | ||
| Q1 24 | — | $298.7M |
| Q4 25 | $-302.0M | $880.8M | ||
| Q3 25 | $-451.4M | $892.7M | ||
| Q2 25 | $-433.5M | $902.0M | ||
| Q1 25 | $-426.2M | $910.5M | ||
| Q4 24 | $-388.7M | $918.6M | ||
| Q3 24 | $-370.2M | $925.4M | ||
| Q2 24 | $-344.2M | $933.1M | ||
| Q1 24 | $-294.3M | $871.6M |
| Q4 25 | $465.9M | $1.9B | ||
| Q3 25 | $364.0M | $1.9B | ||
| Q2 25 | $347.1M | $1.8B | ||
| Q1 25 | $324.0M | $1.8B | ||
| Q4 24 | $343.8M | $1.7B | ||
| Q3 24 | $314.1M | $1.7B | ||
| Q2 24 | $352.3M | $1.7B | ||
| Q1 24 | $373.1M | $1.4B |
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | 0.60× | ||
| Q2 25 | — | 0.57× | ||
| Q1 25 | — | 0.57× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.32× | ||
| Q1 24 | — | 0.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $28.8M |
| Free Cash FlowOCF − Capex | — | $-78.6M |
| FCF MarginFCF / Revenue | — | -85.8% |
| Capex IntensityCapex / Revenue | 0.0% | 117.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-257.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $28.8M | ||
| Q3 25 | $-4.3M | $30.7M | ||
| Q2 25 | $-31.4M | $20.9M | ||
| Q1 25 | $-22.6M | $20.5M | ||
| Q4 24 | $-35.0M | $20.6M | ||
| Q3 24 | $-35.3M | $24.3M | ||
| Q2 24 | $-7.2M | $2.5M | ||
| Q1 24 | $53.8M | $15.2M |
| Q4 25 | — | $-78.6M | ||
| Q3 25 | — | $-51.4M | ||
| Q2 25 | — | $-65.3M | ||
| Q1 25 | — | $-62.7M | ||
| Q4 24 | — | $-72.0M | ||
| Q3 24 | $-35.5M | $-51.3M | ||
| Q2 24 | $-7.3M | $-78.3M | ||
| Q1 24 | $53.8M | $-54.9M |
| Q4 25 | — | -85.8% | ||
| Q3 25 | — | -57.2% | ||
| Q2 25 | — | -73.7% | ||
| Q1 25 | — | -71.3% | ||
| Q4 24 | — | -84.3% | ||
| Q3 24 | -68.7% | -58.5% | ||
| Q2 24 | -9.9% | -91.3% | ||
| Q1 24 | 39.0% | -79.3% |
| Q4 25 | 0.0% | 117.2% | ||
| Q3 25 | 0.0% | 91.4% | ||
| Q2 25 | 0.0% | 97.3% | ||
| Q1 25 | 0.0% | 94.7% | ||
| Q4 24 | 0.0% | 108.4% | ||
| Q3 24 | 0.3% | 86.2% | ||
| Q2 24 | 0.1% | 94.2% | ||
| Q1 24 | 0.1% | 101.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | 0.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
SHEN
| Residential And SMB Incumbent Broadband | $41.5M | 45% |
| Residential And SMB Glo Fiber Expansion Markets | $23.0M | 25% |
| Commercial Fiber | $20.3M | 22% |
| RLEC Other | $6.8M | 7% |
